1. A Decade of Innovation in Rare Diseases 2005 to 2015 www.pharma.org 2016
2. Pariser , A. Yao , L. Rare diseases and orphan drugs. Pediatric drug development: concepts and applications Mulberg , A et al 13 130 148 2013 http://onlinelibrary.wiley.com/book/10.1002/9781118312087
3. Novel New Drugs 2014 Summary, FDA Report, January 2015 http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DrugInnovation/UCM430299.pdf 2016
4. The $2.6 billion pill-methodologic and policy considerations;Avorn;N. Engl. J. Med.,2015
5. Draft Guidance for Industry Internet/Social Media Platforms with Character Space Limitations-Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices, CDER, U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Center for Veterinary Medicine (CVM) Center for Devices and Radiological Health (CDRH) 2014